Performance vs S&P 500

03
Tracked Q4 2025–Q1 2026 -11.7%
S&P 500 total return (same window) -5.4%
Excess return -6.3%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 96.1% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 6 positions

05
Type Streak 8Q trend
EVMN Evommune, Inc. Common Stock $29,445,086 55.80% 1,280,778 $7,518,167
IVA Inventiva S.A. - American Depository Shares $13,064,700 24.76% 2,354,000 $974,700 Down ×1
WVE Wave Life Sciences Ltd. - Ordinary Shares $5,437,500 10.30% 750,000 Up ×1
RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock $2,694,941 5.11% 3,667,585 $-5,810,059 Down ×1
CLNN Clene Inc. - Common Stock $2,125,293 4.03% 431,094 $-2,397,513 Down ×1
SRZNW Surrozen, Inc. - Warrant $2,400 0.00% 150,000 $-600

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
WVE $5,437,500 750,000 10.30%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
EVMN Price move only +0 +$7.5M
RANI Trimmed -2.6M -$5.8M
CLNN Trimmed -339K -$2.4M
IVA Trimmed -246K +$975K
SRZNW Price move only +0 -$600

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
VSTM March 31, 2026 2,000,000 $15,440,000 89.4%
AMPG March 31, 2026 2,555,000 $13,234,900 35.5%
PGEN March 31, 2026 3,000,000 $12,540,000 59.9%
NUVB March 31, 2026 1,250,000 $11,200,000 6.5%
AARD March 31, 2026 476,595 $6,255,309 -63.1%
GBIO March 31, 2026 665,000 $3,777,200 No longer tracked